US2006239974A1PendingUtilityA1
Enhancing cell migration by increasing telomerase activity
Est. expiryMay 9, 2021(expired)· nominal 20-yr term from priority
A61L 26/0066A61K 35/12A61K 35/36A61K 38/45A61L 15/40A61L 15/44A61L 27/3804A61L 27/3813A61L 2300/258A61L 2300/412C12N 5/0629C12N 2510/04C12N 2799/022C12N 2799/027
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
It has been discovered that increasing telomerase activity in cells surrounding a wound promotes wound healing. Replication capacity is enhanced, and the mobility of the epithelial cells can be increased by 3-fold or more. Particular aspects of the invention described in this disclosure include the use of agents that increase telomerase activity in cells at the site of the wound, promoting cells to move to the site and restore an epithelial layer and the underlying stratum.
Claims
exact text as granted — not AI-modified1 . A method for enhancing migration of a cell on a solid surface, comprising contacting the cell with a means for increasing telomerase enzyme activity in the cell.
2 . The method of claim 1 , comprising increasing expression of telomerase reverse transcriptase (TERT) in the cell.
3 . The method of claim 2 , comprising transfecting the cells in vitro with an expression vector encoding TERT.
4 . The method of claim 3 , wherein the vector is an adenovirus vector.
5 . A method for enhancing migration of epithelial cells, comprising increasing telomerase enzyme activity in the cells.
6 . The method of claim 5 , comprising increasing expression of telomerase reverse transcriptase (TERT) in the cells.
7 . The method of claim 6 , comprising transfecting the cells with an expression vector encoding human TERT.
8 . The method of claim 5 , wherein the cells are keratinocytes.
9 . The method of claim 5 , wherein the epithelial cells express at least 2 TPG units of telomerase activity as measured in a telomeric repeat amplification protocol (TRAP) assay.
10 . The method of claim 5 , whereby the epithelial cells migrate on a solid surface at a rate of at least two cell diameters per day.
11 . The method of claim 5 , whereby the rate of migration of epithelial cells across a wound site is increased.
12 . A method for enhancing migration of epithelial cells in vivo, comprising transfecting the cells with an expression vector encoding TERT.
13 . The method of claim 12 , which is a method for treating a wound in which the rate of migration of epithelial cells across a wound site is increased.
14 . The method of claim 13 , comprising administering a pharmaceutical composition comprising an adenovirus expression vector encoding TERT at or around the would site.
15 . The method of claim 13 , wherein the wound is a skin wound.
16 . The method of claim 13 , wherein the composition further comprises a means for retaining the adenovirus vector at or around the wound site.Join the waitlist — get patent alerts
Track US2006239974A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.